Page 151 - CW E-Magazine (23-7-2024)
P. 151

Pharmaceuticals                                                                  Hydrocarbons


 Alembic Pharma gets USFDA’s tentative nod   ENERGY SECURITY

 for Ivosidenib tablets  E&P offers investment opportunities worth $100-bn


 Alembic  Pharmaceuticals said it   diagnosed  Acute Myeloid Leukaemia   by 2030: Petroleum Minister
 has received tentative approval from   (AML) as monotherapy in adults 75   The Exploration  and Production   in E&P, and the Ministry of Petroleum
 the US health regulator for its gene-  years or older, or who have comorbidi-  (E&P) sector offers investment op-  and Natural  Gas (MoPNG) has insti-
 ric Ivosidenib tablets used in the treat-  ties that preclude  the use of intensive   portunities worth $100-bn  by 2030,   tuted sweeping reforms, empowering
 ment of certain types of cancer of bone   induction chemotherapy. It is also indi-  according to Mr. Hardeep Singh Puri,   stakeholders. “We  intend to increase
 marrow and bile duct.  The tentative   cated for adult patients with relapsed or   Minister of Petroleum & Natural Gas.  India’s exploration acreage to 1-million
 approval by the US Food & Drug Ad-  refractory AML and adult patients with   sq. km. by 2030. No- Go areas in
 ministration (USFDA) is for the abbre-  locally advanced or metastatic cholan-  Speaking at the inaugural session   India’s Exclusive  Economic  Zone
 viated new drug application (ANDA)   giocarcinoma who have been previ-  of the fi rst edition of Urja Varta, orga-  (EEZ) have been reduced by almost
 for Ivosidenib tablets of strength 250-mg,  250-mg, of Servier Pharmaceuticals  ously treated, Alembic Pharma added.   nised by the Directorate General of   “Only 10% of our sedimentary  99%,” he added.
 the  company  said  in  a  regulatory  fi l-  LLC, it added.  Ivosidenib tablets, 250-mg, have an   Hydrocarbons (DGH), in New Delhi  basin area is under exploration  today.
 ing.  The approved  ANDA is thera-  estimated market size of  $114-mn in   on July 11, the Minister underscored  After the award of blocks under the  Joint Working Group to address
 peutically equivalent to the reference   The company said Ivosidenib tab-  the 12 months ended March 2024, the   the importance of the E&P sector in  forthcoming  Open  Acreage Licensing  industry concerns
 listed drug product ‘Tibsovo’ tablets,  lets are indicated for patients with newly  company said citing IQVIA data.
       achieving  energy  self-suffi ciency  and  Policy (OALP) Rounds, it will increase   The Minister announced the forma-
       sustaining economic growth. He high-  to 16% by end-2024,” he said.  tion of a Joint Working Group (JWG)
 Zydus Lifesciences gets tentative USFDA nod   lighted the vast potential of India’s   Highlighting the need to streamline  E&P operators, the national oil compa-
                                                                          comprising representatives from private
       26 sedimentary basins, containing
 for BP lowering drug  substantial reserves of crude oil and  operational  and regulatory  processes,  nies, MoPNG, and the DGH to address
       natural gas, which are yet to be fully  Mr. Puri stressed that the government  industry concerns and improve the ease
 Zydus Lifesciences said it has re-  facility in Ahmedabad SEZ-II, it added.   tapped.  is doing its part to catalyse investments  of doing business in the sector.
 ceived tentative approval from the US   Azilsartan is indicated for the treatment
 health regulator to market its generic   of hypertension to lower blood pressure   REDUCING IMPORTS
 Azilsartan Medoxomil tablets used  to   and reduce the risk of fatal and
 treat high blood pressure. The tenta-  nonfatal cardiovascular events, primarily   Government working on policy to offer washed
 tive  approval  by the  US Food and   strokes and myocardial infarctions,
 Drug  Administration (USFDA) is   it added. The medicine can be used   coking coal to steel sector
 for Azilsartan Medoxomil tablets of   either alone or in combination with other
 strengths 40-mg and 80-mg, Zydus   antihypertensive agents, the company   The government will set up eight  with a target of producing 140-mt of  genous  technology  in  coal  gasifi ca-
 Lifesciences said in a regulatory fi ling.   said. It had annual sales of $89-mn in   coking  coal  washeries  to  meet  the  this coal needed by  the steel sector,  tion. “Despite slowdown in the global
 The drug will be manufactured at the   the US, the company said citing IQVIA   demand of steel sector, and ensure that  by 2030. “We are fi nalising the policy,  steel industry, Indian steel industry
 group’s formulation manufacturing   March 2024 data.  by  2029-30,  India has  the capacity to  which once approved, will enable com-  is in a healthy state, and we expect it
       produce as much coking coal as needed,  panies to offer washed coking coal  to grow at a rate of 10%,” he added.
 Camlin’s Subhash Dandekar passes away at 81   besides being  in a position  to supply  to the steel  sector  to blend with  the  Mr. Vidya Rattan Sharma, Senior Member,
       other countries.
                                                                          FICCI Committee on Steel and Mining,
                                         imported coal,” he added.
                                                                          and Vice Chairman, JSP Advisory, said
 Subhash Dandekar, also known   founded Camlin Fine Science, which   Addressing a FICCI workshop on  Importance of coal gasifi cation  coal gasifi cation is the only solution for
 as Dadasaheb Digamber Dandekar,   is toady a leading supplier of perfor-  ‘Coal Matrix for Indian Metals Indus-  Highlighting the importance of coal  meeting the increasing demand of energy
 the founder of Camlin Fine Science   mance chemicals as well as aroma   try’, Mr. M. Nagaraju, Additional Sec-  gasification, Mr. Nagaraju asserted  from the cement and steel industries.
 and chairman emeritus of stationery   ingredients.  retary, Ministry of Coal, Government  that the government has  already ini-
 manufacturer Kokuyo Camlin, died   of India, said the Indian coal sector is  tiated a scheme with a budget  of   Dr. Avinash Kumar Mishra, Execu-
 on July 15 at the age of 85 following   Mr. Dandekar was well-known   witnessing robust growth, reaching  Rs. 8,500-crore to support the private  tive Director (Coal), Railway Board,
 an illness.  for contributions to social aware-  1,000-mt of coal production last year.  and public sectors to set-up coal gasifi ca-  said with the increase in domestic pro-
 ness, art and entrepreneurship. He   “Next year,  we  will produce around  tion plants in the country.  duction of coal, the dependence on
 Mr. Dandekar was instrumental   received several awards, includ-  1,100-mt of coal,” he added.      imports is likely to come down. “There
 in transforming Camlin into a   ing Game Changers of Maharashtra   Mr.  Ashwini Kumar, Economic  has been a steep surge in coal availabi-
 leading name in the production of   award and Lifetime  Achievement   The government,  he said, has  Adviser, Ministry of Steel,  Govt. of  lity in the last two years, which is mostly
 high-quality painting materials. He   Award.  launched  the Coking Coal Mission  India, stressed the need to develop indi-  due to imported coal,” he added.


 150  Chemical Weekly  July 23, 2024  Chemical Weekly  July 23, 2024                                   151


                                      Contents    Index to Advertisers    Index to Products Advertised
   146   147   148   149   150   151   152   153   154   155   156